Motor Complications in Parkinson's Disease: Results from 3343 Patients Followed for up to 12 Years
Movement Disorders Clinical Practice · 2024
DOI: 10.1002/mdc3.14044 ↗Kurz gefasst
Fachartikel in der Zeitschrift Movement Disorders Clinical Practice, 2024. Verfasst von Sacha E Gandhi und 10 weiteren Autor:innen. Beteiligte Einrichtung: School of Neuroscience and Psychology, University of Glasgow, Glasgow, United Kingdom. Hauptthemen laut MEDLINE: Parkinson Disease. Die Arbeit wurde bisher 27-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Parkinson's UK.
Abstract (Originalsprache)
Background
Motor complications are well recognized in Parkinson's disease (PD), but their reported prevalence varies and functional impact has not been well studied.
Objectives
To quantify the presence, severity, impact and associated factors for motor complications in PD.
Methods
Analysis of three large prospective cohort studies of recent‐onset PD patients followed for up to 12 years. The MDS‐UPDRS part 4 assessed motor complications and multivariable logistic regression tested for associations. Genetic risk score (GRS) for Parkinson's was calculated from 79 single nucleotide polymorphisms.
Results
3343 cases were included (64.7% male). Off periods affected 35.0% (95% CI 33.0, 37.0) at 4–6 years and 59.0% (55.6, 62.3) at 8–10 years. Dyskinesia affected 18.5% (95% CI 16.9, 20.2) at 4–6 years and 42.1% (38.7, 45.5) at 8–10 years. Dystonia affected 13.4% (12.1, 14.9) at 4–6 years and 22.8% (20.1, 25.9) at 8–10 years. Off periods consistently caused greater functional impact than dyskinesia. Motor complications were more common among those with higher drug doses, younger age at diagnosis, female gender, and greater dopaminergic responsiveness (in challenge tests), with associations emerging 2–4 years post‐diagnosis. Higher Parkinson's GRS was associated with early dyskinesia (0.026 ≤ P ≤ 0.050 from 2 to 6 years).
Conclusions
Off periods are more common and cause greater functional impairment than dyskinesia. We confirm previously reported associations between motor complications with several demographic and medication factors. Greater dopaminergic responsiveness and a higher genetic risk score are two novel and significant independent risk factors for the development of motor complications.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Neuroscience and Psychology, University of Glasgow, Glasgow, United Kingdom.
- Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, United Kingdom.
- Institute of Neurological Sciences, Glasgow, United Kingdom.
- Oxford Parkinson's Disease Centre, Nuffield Department of Clinical Neuroscience, Oxford University, Oxford, United Kingdom.
- Department of Pharmacology and Toxicology, Faculty of Medicine, Kuwait University, Kuwait City, Kuwait.
- Department of Clinical and Movement Neurosciences, UCL Queen Square Institute of Neurology, University College London, London, United Kingdom.
ORCID-Profile: Sacha E Gandhi, Tanja Zerenner, Huw R Morris, Michele T Hu
Förderung
- Parkinson's UK
Zitieren
APA
Gandhi, S. E., Zerenner, T., Nodehi, A., Lawton, M. A., Marshall, V., Al-Hajraf, F., Grosset, K. A., Morris, H. R., Hu, M. T., Ben-Shlomo, Y., & Grosset, D. G. (2024). Motor Complications in Parkinson's Disease: Results from 3343 Patients Followed for up to 12 Years. Movement Disorders Clinical Practice. https://doi.org/10.1002/mdc3.14044
Vancouver
Gandhi SE, Zerenner T, Nodehi A, Lawton MA, Marshall V, Al-Hajraf F, et al. Motor Complications in Parkinson's Disease: Results from 3343 Patients Followed for up to 12 Years. Movement Disorders Clinical Practice. 2024. doi:10.1002/mdc3.14044
BibTeX
@article{Gandhi2024,
author = {Gandhi, Sacha E and Zerenner, Tanja and Nodehi, Anahita and Lawton, Michael A and Marshall, Vicky and Al-Hajraf, Falah and Grosset, Katherine A and Morris, Huw R and Hu, Michele T and Ben-Shlomo, Yoav and Grosset, Donald G},
title = {Motor Complications in Parkinson's Disease: Results from 3343 Patients Followed for up to 12 Years},
journal = {Movement Disorders Clinical Practice},
year = {2024},
doi = {10.1002/mdc3.14044}
}
EUVIMED